MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis

por Janssen, L. M., den Dekker, B. M., Gilhuijs, K. G. A., van Diest, P. J., van der Wall, E., Elias, S. G.
Publicado 2022

Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA

por Ragusi, M. A. A., van der Velden, B. H. M., van Maaren, M. C., van der Wall, E., van Gils, C. H., Pijnappel, R. M., Gilhuijs, K. G. A., Elias, S. G.
Publicado 2022

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer

por Rigter, L S, Loo, C E, Linn, S C, Sonke, G S, van Werkhoven, E, Lips, E H, Warnars, H A, Doll, P K, Bruining, A, Mandjes, I A, Vrancken Peeters, M J, Wesseling, J, Gilhuijs, K G, Rodenhuis, S
Publicado 2013

Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI

por Schmitz, A. M. T., Veldhuis, W. B., Menke-Pluijmers, M. B. E., van der Kemp, W. J. M., van der Velden, T. A., Viergever, M. A., Mali, W. P. T. M., Kock, M. C. J. M., Westenend, P. J., Klomp, D. W. J., Gilhuijs, K. G. A.
Publicado 2017